ABSTRACT
Quinolones rapidly kill bacteria by two mechanisms, one that requires protein synthesis and one that does not. The latter, which is measured as lethal action in the presence of the protein synthesis inhibitor chloramphenicol, is enhanced by N-1 cyclopropyl and C-8 methoxy substituents, as seen with the highly lethal compound PD161144. In some compounds, such as levofloxacin, the N-1 and C-8 substituents are fused. To assess the effect of ring fusion on killing, structural derivatives of levofloxacin and PD161144 differing at C-7 were synthesized and examined with
Escherichia coli
. A fused-ring derivative of PD161144 exhibited a striking absence of lethal activity in the presence of chloramphenicol. In general, ring fusion had little effect on lethal activity when protein synthesis was allowed, but fusion reduced lethal activity in the absence of protein synthesis to extents that depended on the C-7 ring structure. Additional fused-ring fluoroquinolones, pazufloxacin, marbofloxacin, and rufloxacin, also exhibited reduced activity in the presence of chloramphenicol. Energy minimization modeling revealed that steric interactions of the
trans
-oriented N-1 cyclopropyl and C-8 methoxy moieties skew the quinolone core, rigidly orient these groups perpendicular to core rings, and restrict the rotational freedom of C-7 rings. These features were not observed with fused-ring derivatives. Remarkably, structural effects on quinolone lethality were not explained by the recently described X-ray crystal structures of fluoroquinolone-topoisomerase IV-DNA complexes, suggesting the existence of an additional drug-binding state.
摘要
喹诺酮类药物通过两种机制迅速杀死细菌,一种需要蛋白质合成,另一种不需要。后者是指在蛋白质合成抑制剂氯霉素存在时的致死作用,N-1 环丙基和 C-8 甲氧基取代基增强了这种作用,高致死性化合物 PD161144 就具有这种作用。在某些化合物(如左氧氟沙星)中,N-1 和 C-8 取代基融合在一起。为了评估环融合对杀伤力的影响,我们合成了左氧氟沙星和 PD161144 在 C-7 处不同的结构衍生物,并用大肠杆菌进行了检测。
大肠杆菌
.PD161144 的一种环状融合衍生物在氯霉素存在的情况下明显缺乏致死活性。一般来说,在允许蛋白质合成的情况下,环融合对致死活性的影响很小,但在没有蛋白质合成的情况下,融合会降低致死活性,其程度取决于 C-7 环结构。其他融合环氟喹诺酮类药物帕珠沙星、马波沙星和芦氟沙星在氯霉素存在的情况下也表现出活性降低。能量最小化模型显示,反式氟哌酸和环氟哌酸的立体相互作用会导致活性降低。
反式
-N-1 环丙基和 C-8 甲氧基的立体相互作用使喹诺酮核心偏斜,使这些基团垂直于核心环刚性定向,并限制了 C-7 环的旋转自由度。在融合环衍生物中没有观察到这些特征。值得注意的是,最近描述的氟喹诺酮-拓扑异构酶 IV-DNA 复合物的 X 射线晶体结构无法解释结构对喹诺酮致死性的影响,这表明还存在另一种药物结合态。